Alan S. Lowenthal sold Biomarin Pharmaceutical Inc (NASDAQ: BMRN)
Alan S. Lowenthal (D-CA), a U.S. Representative, has disclosed 9 trades in Biomarin Pharmaceutical Inc (BMRN) since 2018, 5 purchases and 4 sales, worth an estimated $49K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Alan S. Lowenthal sold $217.10 of Biomarin Pharmaceutical Inc (NASDAQ: BMRN) on August 14, 2019. Since that trade, BMRN is down -14.42% against the S&P 500 up +183.85%, an outperformance of -198.27%.
Across these filings, Alan S. Lowenthal has been a net buyer of BMRN (a buy-to-sell ratio of 1.25). The most recent disclosed BMRN transaction shown was dated August 15, 2019. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Alan S. Lowenthal's BMRN trades vs the price
BMRN is down -14.42% since Alan S. Lowenthal sold on August 14, 2019, versus +183.85% for the S&P 500.
Performance since this trade
All Alan S. Lowenthal BMRN trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Alan S. Lowenthal & BMRN trading FAQ
Is it legal for Alan S. Lowenthal to trade Biomarin Pharmaceutical Inc (BMRN) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Biomarin Pharmaceutical Inc (BMRN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Alan S. Lowenthal sell BMRN?
Alan S. Lowenthal disclosed a sale of $217.10 of Biomarin Pharmaceutical Inc (BMRN) on August 14, 2019, according to public STOCK Act filings.
How has BMRN performed since Alan S. Lowenthal's trade?
Since Alan S. Lowenthal sold BMRN on August 14, 2019, the stock is down -14.42%, versus +183.85% for the S&P 500 over the same period, an outperformance of -198.27%.
How many times has Alan S. Lowenthal traded BMRN?
Alan S. Lowenthal has disclosed 9 BMRN trades since 2018 (5 purchases and 4 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BMRN trades?
Quantellect tracks every disclosed congressional trade in Biomarin Pharmaceutical Inc (BMRN) on the Biomarin Pharmaceutical Inc congressional trading page, which aggregates filings across all members of Congress.
Alan S. Lowenthal's BMRN tradesAll congressional filings for Biomarin Pharmaceutical IncAlan S. Lowenthal's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.